| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/23/2013 | EP2547679A1 2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.6]nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor |
| 01/23/2013 | EP2547678A1 Anti-infective compounds |
| 01/23/2013 | EP2547677A2 Inhibitors of semicarabazide - sensitive amine oxidase |
| 01/23/2013 | EP2547338A2 Imidazopyridine compounds, compositions and methods of use |
| 01/23/2013 | EP2547203A1 Ccr5 modulators for treating hiv |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892767A Compounds for the treatment of hepatitis c |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102887898A Method for separating and purifying nevirapine |
| 01/23/2013 | CN102887897A Preparation method of methyl 2-(imidazo-[1,2-a]pyridyl-3-yl)acetate |
| 01/23/2013 | CN102887896A Preparation method of 2-(imidazo-[1,2-a]pyridyl-3-yl)acetonitrile |
| 01/23/2013 | CN102887895A Pyridopyrimidine mammalian target of rapamycin (mTOR) inhibitor |
| 01/23/2013 | CN102887891A N4-phenyl-quinaz0line-4 -amine derivatives and related compounds |
| 01/23/2013 | CN102344449B Heterocyclic-fused naphthalimide and preparation method and application thereof |
| 01/23/2013 | CN101993443B Novel crystal form of benzilic acid nortropine easter and preparation method thereof |
| 01/23/2013 | CN101940214B Spiropiperidine derivatives for controlling pests |
| 01/23/2013 | CN101910127B (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 01/23/2013 | CN101628913B Compound as estrogen-related receptor modulator and application thereof |
| 01/23/2013 | CN101248072B 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 01/23/2013 | CN101035788B Method for preparing halogenated rylen-carboximides by halogenation of rylen-carboximides with elementary halogen in a two-phase mixture comprising an organic solvent and water |
| 01/22/2013 | US8357803 Process for the preparation of 2,3,4,9-tetrahydro-1H-β-carbolin-3-carboxylic acid esters |
| 01/22/2013 | CA2650932C Substituted spirocyclic cgrp receptor antagonists |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/22/2013 | CA2560293C Substituted 1,4,8-triazaspiro[4.5]decan-2-on compounds |
| 01/22/2013 | CA2515777C Biphenyl derivatives |
| 01/17/2013 | WO2013009582A1 TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF |
| 01/17/2013 | WO2013009013A2 Novel compound and organic electronic device using same |
| 01/17/2013 | WO2013008217A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | WO2013007768A1 Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors |
| 01/17/2013 | WO2013007765A1 Fused tricyclic compounds for use as inhibitors of janus kinases |
| 01/17/2013 | WO2013007663A1 2-benzylsulfanyl[1,3,4]-oxadiazole derivatives, and medical use thereof |
| 01/17/2013 | WO2013007184A1 Antineoplastic drug tetrahydronaphthalene amide-group compound and pharmaceutically acceptable salt, preparation method and use thereof |
| 01/17/2013 | WO2013007167A1 Crystal form i of salt of dipeptidyl peptidase-iv inhibitor and preparation method and use thereof |
| 01/17/2013 | WO2013007106A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/17/2013 | WO2012068234A3 Antiviral compounds |
| 01/17/2013 | US20130018187 Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds |
| 01/17/2013 | US20130018075 Heterocyclic inhibitors of mek and methods of use thereof |
| 01/17/2013 | US20130018068 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/17/2013 | US20130018050 Bi-functional pyrazolopyridine compounds |
| 01/17/2013 | US20130018049 Azaindole Compounds and Methods for Treating HIV |
| 01/17/2013 | US20130018048 Oxazole derivatives useful as modulators of faah |
| 01/17/2013 | US20130018046 Acetylenic Heteroaryl Compounds |
| 01/17/2013 | US20130018043 Aminomethyl quinolone compounds |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/17/2013 | US20130018038 Chemical compounds |
| 01/17/2013 | US20130018034 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
| 01/17/2013 | US20130018033 Raf inhibitor compounds and methods of use thereof |
| 01/17/2013 | CA2841932A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | CA2841095A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/16/2013 | EP2546254A1 Imidazo[4,5-C]pyridine compounds and methods of antiviral treatment |
| 01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
| 01/16/2013 | EP2545918A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 01/16/2013 | EP2545058A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/16/2013 | EP2545054A1 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
| 01/16/2013 | EP2545053A1 Azaisoquinolinone derivatives as nk3 antagonists |
| 01/16/2013 | EP2545052A1 Imidazopyridines syk inhibitors |
| 01/16/2013 | EP2545051A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | EP2545050A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | EP2545046A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | CN102884156A Light-emitting device material and light-emitting device |
| 01/16/2013 | CN102884071A Novel artificial fluorescent bases |
| 01/16/2013 | CN102884063A Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
| 01/16/2013 | CN102884062A Aminopyrimidine kinase inhibitors |
| 01/16/2013 | CN102884059A N-酰基环胺衍生物或其可药用盐 N- acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | CN102884049A Heterocyclic amides as ROCK inhibitors |
| 01/16/2013 | CN102875552A Composite solvent for efficiently extracting alkaloids |
| 01/16/2013 | CN102875551A Chloro alkaloid compound and preparation and application thereof |
| 01/16/2013 | CN102875550A 1,3,7-tri-substituted-diazabicyclo[3,3,1] nonane derivative and preparation method thereof |
| 01/16/2013 | CN102875549A 7-arylamine/methylamino-5-amino-6-azaindole derivative, preparation method and application |
| 01/16/2013 | CN102875548A Oxime-based method for synthesis of pyridine derivative by [2+2+2] cycloaddition |
| 01/16/2013 | CN102875441A Plexxikon inc |
| 01/16/2013 | CN102872915A Iron catalyst system for preparation of pyridine derivatives and its application |
| 01/16/2013 | CN102870791A Application of triazol pyridine derivative in preparing monocotyledon-resistant pesticide |
| 01/16/2013 | CN102250090B Method for preparing minodronic acid intermediate |
| 01/16/2013 | CN102180875B Preparation method of triazolopyridine derivative |
| 01/16/2013 | CN101678129B Radioactive pet agents for imaging CCR5 in vivo |
| 01/15/2013 | US8354426 Naphthyridine derivative monohydrate and method for producing the same |
| 01/15/2013 | US8354425 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/15/2013 | US8354416 3-[2-{[3-(diethylamino)propyl]amino}-8-(2,6-difluorophenyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yl]-5-fluoro-4-methyl-N-(1-methylethyl)benzamide; treating CSBP/p38 kinase mediated diseases; cytokine suppressive anti-inflammatory drugs; mitogen-activated protein kinase inhibitors |
| 01/15/2013 | US8354414 Substituted bicyclic pyrimidines |
| 01/15/2013 | CA2702834C Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 01/15/2013 | CA2693997C Viral polymerase inhibitors |
| 01/15/2013 | CA2560253C Prodrugs of piperazine and substituted piperidine antiviral agents |
| 01/10/2013 | WO2013006738A1 Compounds for the treatment of hiv |
| 01/10/2013 | WO2013006485A1 Fused benzoxazepinones as ion channel modulators |
| 01/10/2013 | WO2013005354A1 Heterocyclic compound |
| 01/10/2013 | WO2013004709A1 Indolylmaleimides as soft pan-pkc inhibitors |
| 01/10/2013 | WO2013004617A1 Pyrazolopyridines useful in the treatment of disorders of the central nervous system |
| 01/10/2013 | WO2013004332A1 Substituted azaheterocycles for the treatment of cancer |
| 01/10/2013 | WO2012138172A3 Novel organometallic compound, and organic light-emitting diode using same |
| 01/10/2013 | WO2012096832A3 Hdac inhibiting derivatives of camptothecin |
| 01/10/2013 | US20130012521 Apoptosis signal-regulating kinase inhibitors |
| 01/10/2013 | US20130012518 Bicyclic compounds and their uses as dual c-src / jak inhibitors |
| 01/10/2013 | US20130012517 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012516 6-CYCLOAMINO-3-(PYRID-4-YL)IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012508 Novel anxiolytic compounds |
| 01/10/2013 | US20130012505 Benzonaphthyridinamines as autotaxin inhibitors |
| 01/10/2013 | US20130012500 Organic compounds |